Abstract
Therapeutic Options in Hypertrophic Cardiomyopathy Hypertrophic cardiomyopathy (HCM) is one of the more common hereditary cardiac conditions. Several hundreds of mutations in genes coding for sarcomeric or energy metabolism proteins have been found to be associated with the phenotype. Myocardial disarray and fibrosis are the prominent histological findings of the disease. A more common (70%) obstructive (HOCM) has to be distinguished from the less common (30%) non-obstructive phenotype (HNCM). Symptoms include exercise limitation due to dyspnea or angina pectoris, palpitations, or dizziness.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
